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Abstract
Background: Medication errors can occur at any of the three steps of the medication use process: prescribing,
dispensing and administration. We aimed to determine the incidence, type and clinical importance of drug
administration errors and to identify risk factors.
Methods: Prospective study based on disguised observation technique in four wards in a teaching hospital in
Paris, France (800 beds). A pharmacist accompanied nurses and witnessed the preparation and administration of
drugs to all patients during the three drug rounds on each of six days per ward. Main outcomes were number,
type and clinical importance of errors and associated risk factors. Drug administration error rate was calculated with
and without wrong time errors. Relationship between the occurrence of errors and potential risk factors were
investigated using logistic regression models with random effects.
Results: Twenty-eight nurses caring for 108 patients were observed. Among 1501 opportunities for error, 415
administrations (430 errors) with one or more errors were detected (27.6%). There were 312 wrong time errors, ten
simultaneously with another type of error, resulting in an error rate without wrong time error of 7.5% (113/1501).
The most frequently administered drugs were the cardiovascular drugs (425/1501, 28.3%). The highest risks of error
in a drug administration were for dermatological drugs. No potentially life-threatening errors were witnessed and
6% of errors were classified as having a serious or significant impact on patients (mainly omission). In multivariate
analysis, the occurrence of errors was associated with drug administration route, drug classification (ATC) and the
number of patient under the nurse’s care.
Conclusion: Medication administration errors are frequent. The identification of its determinants helps to
undertake designed interventions.
Keywords: Hospital care, Medication errors, Direct observation
Background
Since the release of the report To Err Is Human, patient
safety has risen to the forefront of healthcare issues [1].
Medication errors can occur during any of the three
steps of the medication use process: from prescription,
medication delivery to dispensing to the patient. Reviews
on medication errors [2-10], prescription errors [11] or
dispensing errors [12] are numerous. The evaluation
and improvement of drug administration process are
key elements in patient safety. A review of drug
administration errors detected by the observation tech-
nique [13] revealed methodological limitations in studies
evaluating the administration process: no standardized
definition of error types and error rate, lack of informa-
tion about the selection method of nurses observed and
number of nurses observed, the level of experience of
nurses, the number of patients or information on the
observation technique [14-28].
To overcome the limits described above, we aimed to
assess the frequency, type, potential clinical significance
and determinants of drug administration errors detected
by direct observation in adult in-patients.
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Setting
The study was conducted in four adult wards (90 beds)
at a teaching hospital in Paris, France (800 beds): immu-
nology-cardiology ward, nephrology ward, vascular med-
ical ward and cardiovascular surgical ward. These four
wards are the only ones for which the drug doses are
prepared daily by the pharmacy. Prescriptions were writ-
ten by physicians, using the same computerized physi-
cian order entry system (DxCare
®, Medasys). The
hospital pharmacy validated orders and delivered the
prescribed drugs to each ward, on a unit-dose basis
except for drugs prescribed as needed. If necessary, the
nurses obtained the drugs from secure and automated
medication cabinets (Omnicell
® Inc.) available in each
ward. Each nurse was in charge of 6 to 8 patients.
Study design
Disguised direct observation was used for the detection
of drug administration errors [13], because this
approach gives more efficient, objective, and reliable
results than spontaneous reporting or patient chart
reviews [29-31]. Head nurses and physicians were
informed about the objectives and the nurses who were
observed were told that a pharmacist was evaluating the
process of drug administration with the aim of improv-
ing it. We used a single observer, to avoid problems of
interobserver variability. At the start of the observation
period, each nurse gave written consent for observation
and had the option of refusing to be observed. The
observer was a clinical pharmacist and received a one-
month training with a senior pharmacist before the start
of the study.
For each observation round and ward, the observation
order of nurses was randomized for identification of the
nurse to be observed. Patients were not selected. The
observer watched the selected nurses preparing and
administering medication. Observations were carried out
on six consecutive days per ward (including Saturday),
for three drug rounds per day (8 am, 12 pm, 6 pm).
Recorded observations were compared immediately after
observation with the physician orders. Because the
observer saw the order after drug administration, she
was unable to prevent some errors. But if she was aware
of an imminent potential error, she intervened to pre-
vent it.
Emergency drugs, parenteral nutrition and drugs pre-
scribed as needed were not observed as the delivery of
these medications did not follow the unit-dose process
described above. Non-permanent nurses were not
included in the study.
The following data were collected: characteristics of
the nurse (age, sex, years of experience and years in the
unit); nurse-to-patient ratio; nurse workload (number of
patients under the care of each nurse, including patients
who were admitted on that day) and number of inter-
ruptions during the drug administration round, and
characteristics of the drugs (Anatomical Therapeutic
Chemical (ATC) classification, unit-dose prepared by
the pharmacy, route, pharmaceutical form, dose and
time of drug administration).
The study was not considered as research but as rou-
tine care. It was part of an audit for quality improve-
ment and was considered exempted from ethical
approval. All data were studied anonymously.
Outcomes
The main outcome assessed was error rate. Error rate
without wrong time errors, types of errors, severity of
errors and risk factors were also evaluated.
Errors
To overcome the limits found in the review we con-
ducted, we standardized the drug administration error
rate using the same denominator (see below) and the
types of errors defined by the American Society of
Health-system Pharmacists (ASHP). Drug administration
errors were classified into the nine categories of the
ASHP: omission error (failure to administer an ordered
dose to a patient), wrong time error (administered more
than one hour before or after the specified time),
unauthorized drug error (dose given to the wrong
patient, unordered drugs), wrong dose error, wrong
dosage-form error, wrong drug-preparation error (incor-
rect dilution or reconstitution, mixing drugs that are
physically incompatible and inadequate product packa-
ging), wrong administration technique error (doses
administered via the wrong route (different from the
route prescribed), via the correct route but at the wrong
site, and at the wrong rate of administration), deterio-
rated drug error (use of expired drugs or improperly
stored drugs) and other medication error (included any
drug administration errors not fitting into the above
predefined categories) [32]. The error rate was calcu-
lated using the Total Opportunities for Errors (TOE),
which is the sum of all doses ordered plus all the unor-
dered doses given [33]. The drug administration error
rate was then calculated as the number of administra-
tions with one or more errors divided by the TOE and
multiplied by 100. We also calculated the error rate
without wrong time errors, as this type of error is a
matter of much debate. Some authors recommended
that studies on medication errors should report both the
error rates with and without timing errors [29,34]. For
injectable drugs, an administration of drug and solvent
corresponded to one opportunity for error. Any given
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so it was possible that the sum of errors types was
greater than the total number of administrations with at
least one error. But an error could only be classified in
one category of error.
A panel of senior experts composed of four physicians,
three head nurses and two pharmacists evaluated the
severity of each error anonymously according to a
three-category scale: no clinical impact, serious or signif-
icant clinical impact, life-threatening impact on the
patient [35].
Statistical analysis
Categorical variables are reported as frequencies (per-
centages) and numerical variables are reported as med-
ians (minimum and maximum). The drug
administration error rate was calculated with and with-
out wrong time errors. We investigated the relationship
between the occurrence of errors (error rate and error
rate without wrong time errors) and potential risk fac-
tors (characteristics of the nurse and drug), using logis-
tic regression models with random effects (intercepts) to
take multiple observations for the same patient and the
same nurse into account. All risk factors were analyzed
in univariable and multivariable analyses. The final
model was obtained by removing all factors not signifi-
cant at the 5% level. Results are expressed as odds ratios
(OR), with the 95% confidence intervals (CI). Data were
analyzed with SAS
® version 9.1 (SAS Institute, Cary,
NC, USA).
Results
Study participants
Disguised direct observation was carried out during 72
drug rounds. All the nurses agreed to participate. Table
1 lists the characteristics of the nurses. There were 28
nurses (all female): six in the immunology-cardiology
ward, seven each in the nephrology ward and cardiovas-
cular surgical ward and eight in the vascular medical
ward. Half the nurses were observed at least twice (min-
max: 1-6 observation periods). Drug rounds lasted a
median of 1 h 12 min (min-max: 15 min-2 h 45 min).
During the study period, 108 patients were under the
care of the nurses studied. A median of six patients per
drug round was observed (min-max: 2-9).
Error rate
In total, we recorded 1501 TOE. At least one error was
detected in 415 of the 1501 TOE (error rate = 27.6%),
with 430 errors identified in total. For 13 administra-
tions, 2 errors were observed and for one administra-
tion, 3 errors were observed. Of the 14 administrations
with more than one error, 10 included a wrong time
error (see details in footnotes of Table 2). After exclu-
sion of the 312 wrong time errors, 113 of the 1501
administrations (TOE) remained erroneous (415-312 +
10) corresponding to an error rate without wrong time
error of 7.5%.
Types of errors
Wrong time errors were the principal type of errors
observed (n = 312, 72.6%), followed by errors of omis-
sion (n = 60, 14.0%), and unauthorized drug errors (n =
16, 3.7%). There were 10 errors (2.3%) with the type
“Other medication error” corresponding to administra-
tion of thyroid hormones with food, whereas these
drugs should be administered to fasting patients. Wrong
dose errors, wrong dosage-form errors, wrong drug-pre-
paration errors, and wrong administration technique
errors were rare (n = 8 for each type, 1.9%). There was
no deteriorated drug error (see additional file 1).
Drug classification
The type of drugs administered and the error rate
according to ATC drug classification are described in
Table 2 and Additional file 1. The most frequently
administered drugs were the cardiovascular drugs (425/
1501, 28.3%) (C in ATC classification), the central ner-
vous system drugs (279/1501, 18.6%) (N in ATC classifi-
cation), followed by the gastrointestinal drugs (270/
1501, 18.0%) (A in ATC classification).
More than a half of administrations of dermatological
drugs (D in ATC classification) and sensory organs
drugs (S in ATC classification) had an error but they
were rarely prescribed (0.5% and 0.7% respectively). The
most frequently administered drugs (C, N and A in
ATC classification) had error rates of 20.5%, 33.7% and
31.8% respectively.
The administration or omission of 182 different drugs
were incorrect. The first ten most administered drugs
were oral acetaminophen (37% of administrations had
an error), esomeprazol (37%), acetylsalicylic acid (22%),
oral furosemide (9%), bisoprolol (28%), atorvastatin (9%),
calcium heparin (32%), oral tramadol (22%), amlodipine
(16%) and oral potassium chloride (31%).
Severity of errors
The observer intervened three times to prevent errors
from occurring: corresponding to 5 drugs almost admi-
nistered to the wrong patient, one ganciclovir
Table 1 Characteristics of the nurses
Nurses N = 28
Age, median [min - max] 29 [21-50]
Women, n (%) 28 (100)
Years of experience, median [min - max] 5 [0.8-27.5]
Years in the unit, median [min - max] 3.3 [0.03-10.0]
Full-time job, n (%) 26 (93)
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mg) and one amoxicillin/clavulanic acid drug almost
administered instead of prescribed amoxicillin. No
patient harm was observed.
The expert panel classified 406 (94%) of the 430 errors
as having no clinical impact on the patient and 24 (6%)
as having serious or significant impact. Most of these
errors were omissions. No potentially life-threatening
errors were witnessed.
Risk factors for errors
Univariable logistic regression analysis indicated that the
occurrence of errors was significantly associated with
administration route, drug ATC and number of patients
under the nurse’sc a r e( T a b l e3 ) .T h e r ew a san o ns i g -
nificant trend towards an increase in the occurrence of
errors towards the end of the week. There was a non
significant trend towards a decrease in the occurrence
of errors with increase age of the nurse (OR associated
with a five-year increase in age: 0.81 [95% CI: 0.62 to
1.06], p = 0.127). No significant effects of clinical unit,
week day, drug round, unit-dose preparation by the
pharmacy, interruptions and number of patients receiv-
ing drugs were found. The removal of medication from
secure medication cabinets, by the nurses, was not asso-
ciated with errors.
In the multivariable analysis (Table 3), the same three
factors were associated with the occurrence of errors.
The risk of error was higher for administrations by
injection (OR versus the oral route: 3.30 [95% CI: 2.01
to 5.44], p < 0.001) and for nurses with larger numbers
of patients under their care (OR associated with a one-
patient increase: 1.22 [95% CI: 1.04 to 1.42], p =0 . 0 1 3 ) .
The highest risks of error in a drug administration were
for dermatological drugs (D in ATC classification) and
sensory organs drugs (S in ATC classification) but the
confidence intervals were large due to small sizes. The
risk of error was significantly higher for respiratory sys-
tem drugs (R in ATC classification), systematic hormo-
nal drugs (H in ATC classification), anti-infective drugs
for systemic use (J in ATC classification), central ner-
vous system drugs (N in ATC classification) and gastro-
intestinal drugs (A in ATC classification) than for
cardiovascular drugs, the most frequently administered
drugs (C in ATC classification). Analysis of risk factors
for errors excluding wrong time errors highlighted the
same factors. Since the frequency of event was more
rare (113/1501), the drug ATC (14 levels) could not be
evaluated as a risk factor in a model with random
effects. Drug ATC was highly significant in the univari-
ate analysis (logistic regression model without random
effects: p < 0.001). The multivariable analysis (without
Table 2 Types of drug administration errors related to drug ATC classification
Drug ATC* Number of TOE (column%) Number of errors (column%) Number of TOE† with errors (column%) Error rate‡
A 270 (18.0) 90 (20.9) 86 (20.7)
a 31.8%
B 201 (13.4) 38 (9.5) 38 (9.2) 18.9%
C 425 (28.3) 89 (20.7) 87 (21.0)
b 20.5%
D 8 (0.5) 7 (1.7) 7 (1.7) 87.5%
G 26 (1.7) 6 (1.5) 6 (1.4) 23.1%
H 40 (2.7) 18 (4.2) 16 (3.9)
c 40.0%
J 150 (10.0) 55 (12.8) 50 (12.0)
d 33.3%
L 22 (1.5) 3 (0.7) 3 (0.7) 13.6%
M 13 (0.9) 1 (0.2) 1 (0.2) 7.7%
N 279 (18.6) 96 (22.3) 94 (22.7)
e 33.7%
R 36 (2.4) 15 (3.7) 15 (3.6) 41.7%
S 10 (0.7) 6 (1.5) 6 (1.4) 60.0%
V 16 (1.1) 4 (1.0) 4 (1.0) 25.0%
Others 5 (0.3) 2 (0.5) 2 (0.5) 40.0%
All 1501 430 415 27.6%
* ATC classification detailed in additional file
† TOE: Total Opportunities for Errors
‡ Error rate = Number of TOE with errors/Number of TOE
a 4 administrations with two types of errors (Wrong time error + Wrong drug-preparation error: 3, Wrong drug-preparation error + Wrong administration
technique error: 1)
b 2 administrations with two types of errors (Wrong time error + Unauthorized drug error: 1, Wrong time error + Wrong administration technique error: 1)
c 2 administrations with two types of errors (Wrong time error + Other medication error: 1, Wrong dose error + Other medication error: 1)
d 3 administrations with two types of errors (Wrong time error + Wrong dosage-form error: 1, Wrong dose error + Wrong drug-preparation error: 1, Wrong drug-
preparation error + Wrong administration technique error: 1), 1 administration with three types of errors (Wrong time error + Unauthorized drug error + Wrong
drug-preparation error)
e 2 administrations with two types of errors (Wrong time error + Wrong dose error: 1, Wrong time error + Wrong dosage-form error: 1)
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Administrations Univariable analysis Multivariable analysis*
Variable, n (%) No error (N =
1086)
Error (N =
415)
OR [95% CI]† Global
P†
OR [95% CI]† Global
P†
Unit 0.64
Nephrology 230 (21.2) 54 (13.0) 1
Immunology-Cardiology 309 (28.5) 125 (30.1) 1.29 [0.37-4.52]
Vascular medical 266 (24.5) 113 (27.2) 1.56 [0.48-5.15]
Cardiovascular surgical 281 (25.9) 123 (29.6) 2.17 [0.65-7.23]
Day 0.104
Tuesday 192 (17.7) 56 (13.5) 1
Monday 175 (16.1) 51 (12.3) 1.52 [0.88-2.64]
Wednesday 199 (18.3) 73 (17.6) 1.43 [0.75-2.70]
Thursday 168 (15.5) 95 (22.9) 2.56 [1.33-4.92]
Friday 165 (15.2) 86 (20.7) 1.81 [0.95-3.45]
Saturday 187 (17.2) 54 (13.0) 1.69 [0.80-3.56]
Drug round 0.68
Noon 140 (12.9) 61 (14.7) 1
Morning 504 (46.4) 169 (40.7) 0.87 [0.59-1.29]
Night 442 (40.7) 185 (44.6) 0.77 [0.40-1.46]
Route < .0001 < .0001
Oral 975 (89.8) 327 (78.8) 1 1
Injectable 81 (7.5) 50 (12.0) 2.42 [1.58-3.71] 3.30 [2.01-5.44]
Other 30 (2.8) 30 (7.2) 4.61 [2.39-8.89] 1.89 [0.72-4.94]
Drug ATC** < .0001 < .0001
C 338 (31.1) 87 (21.0) 1 1
M 12 (1.1) 1 (0.2) 0.28 [0.03-2.32] 0.30 [0.04-2.53]
L 19 (1.7) 3 (0.7) 0.51 [0.13-1.93] 0.65 [0.17-2.48]
B 163 (15.0) 38 (9.2) 0.95 [0.59-1.53] 0.61 [0.36-1.03]
V 12 (1.1) 4 (1.0) 1.03 [0.25-4.25] 1.09 [0.26-4.54]
G 20 (1.8) 6 (1.4) 1.51 [0.52-4.42] 1.51 [0.51-4.42]
Others 3 (0.3) 2 (0.5) 1.60 [0.20-12.65] 1.47 [0.18-11.69]
A 184 (16.9) 86 (20.7) 1.69 [1.12-2.53] 1.61 [1.06-2.42]
N 185 (17.0) 94 (22.7) 1.94 [1.30-2.91] 2.01 [1.34-3.02]
J 100 (9.2) 50 (12.0) 2.61 [1.58-4.30] 1.96 [1.16-3.30]
H 24 (2.2) 16 (.3.9) 3.38 [1.58-7.26] 3.35 [1.57-7.18]
R 21 (1.9) 15 (3.6) 4.49 [1.86-10.85] 3.09 [1.06-8.99]
S 4 (0.4) 6 (1.4) 7.55 [1.51-37.74] 4.49 [0.68-29.66]
D 1 (0.1) 7 (1.7) 38.28 [3.85-
380.34]
26.10 [2.17-
314.30]
Unit-dose prepared by the pharmacy 0.22
No 216 (19.9) 98 (23.6) 1
Yes 870 (80.1) 317 (76.4) 0.81 [0.58-1.13]
Interruptions†† 0.82
No 1037 (95.5) 339 (95.8) 1
Yes 49 (4.5) 15 (4.2) 0.92 [0.47-1.82]
Nurse’s age‡‡ 30 (27-35) 29 (27-33) 0.81 [0.62-1.06]
‡
0.127
Number of patient under nurse’s care‡‡ 8 (7-9) 9 (7-9) 1.21 [1.05-1.41]
#
0.011 1.22 [1.04-1.42]
#
0.013
Number of patient with drugs to be
administered‡‡
6 (6-8) 7 (6-8) 1.04 [0.92-1.18]
#
0.50
* Terms not significant at the 5% level were removed (backward selection)
† Derived from the logistic regression model with random effects
‡ OR for a 5-year increase
# OR for a 1-patient increase
** ATC classification detailed in additional file
†† Errors were observed on 354 administrations only (and not 415) due to omissions.
‡‡ Median (Q1-Q3)
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errors excluded) was higher for administrations by injec-
tion (OR versus the oral route: 6.89 [95% CI: 4.06 to
11.70], p < 0.001), tended to be lower with increase age
of the nurse (OR associated with a five-year increase in
age: 0.78 [95% CI: 0.60 to 1.02], p = 0.069), and surpris-
ingly there was a non significant trend towards a
decrease of risk of error (wrong time errors excluded)
with an increase of the number of patients under the
nurse’s care (OR associated with a one-patient increase:
0.75 [95% CI: 0.56 to 1.01], p = 0.060).
Discussion
Drug administration errors were common in the wards
studied. An error rate of 27.6% was found, decreasing to
7.5% when wrong time errors were excluded. Most of
the errors (94%) were unlikely to cause lasting harm,
but 6% were serious. By extrapolation to the whole hos-
pital (800 beds), a rate of 6% serious errors would have
meant more than 200 such errors every month. The fac-
tors associated with errors were administration route,
drug ATC and number of patients under the nurse’s
care. Unit-dose preparation by the pharmacy was not
associated with a higher occurrence of errors than the
removal of the drug from a secure medication cabinet.
In the literature, there is a high heterogeneity in the
methodologies, leading to heterogeneity in the results.
In the systematic review we conducted, wrong time
errors followed by omissions are the most frequent
types of errors reported. In addition, the error rate with-
out wrong time errors ranges from 1% [36,37] to 48%
[38]. In a previous study in two adult units (geriatric
and cardiovascular-thoracic surgery unit), error rates
reached 14.9% with wrong time errors and 11% without
wrong time errors [39]. The total error rate in our study
was higher than those in the study by Chua and collea-
gues (11.4% in an adult hematology unit), but the error
rates without wrong time errors was similar to that
reported here (8.7%) [18].
We did not find an association with the unit, the day
of observation and the drug rounds. As our study, Prot
and colleagues found an association between errors and
drug ATC classification (cardiovascular, anti-infective
and central nervous system drugs) [23]. Chua and col-
leagues showed an association between errors and
injectable route administration compared to oral route
[18]. Finally, nurse workload was a risk factor of medica-
tion administration errors in the study by Tissot and
colleagues whereas injectable administration was not
associated with errors [39].
We chose to use disguised observation technique in
this study. The observation period was relatively long.
We used a single observer specifically trained for this
study. To overcome the limits found in our review, we
standardized the drug administration error rate using
the same denominator (TOE) and the types of errors
(ASHP classification). We reported the number of drug
administration’s with one or more errors in order to cal-
culate an error rate excluding some types of errors.
Finally, characteristics of hospital are presented (coun-
try, types of units, delivery system, characteristics of
nurses observed). Our study has several potential limita-
tions. First, it was a single-center study. Observation is
very time-consuming and can therefore be carried out
for very long periods of time. We did not observe nurses
during the Sundays, and thus the applicability of the
results for work at these times is unknown. It is also
possible that nurses changed their behaviors when
observed because they were aware that they were being
observed to identify problems in the medication use
process. However, Allan and Barker showed that dis-
guised observation decreasest h eH a w t h o r n ee f f e c to n
observed nurses [29]. We did not observe non-perma-
nent nurses as their agreement could not be obtain.
However they represented less than 10% of the nurses
during the observation period. Medication with high
risk like chemotherapy drugs were rarely prescribed in
the 4 units observed therefore no error of such adminis-
tration was detected.
Different interventions have been proposed to improve
the drug administration process. This study shows that
those interventions should be adapted to the local con-
text and the type of errors observed. For example, intro-
duction of bar-code medication administration systems
together with awareness of nurses could reduce some
errors like omissions and wrong time (the two most fre-
quent errors found in our study). Wrong administration
technique including injectable drugs could be decrease
with nurse training and awareness to manipulate inject-
able drugs.
Conclusion
Medication safety issues are an important element of the
medication use process in hospitals. Drug administration
errors are frequent. Standardization of drug administra-
tion error rate using the same denominator (TOE) and
types of errors remains essential for further studies.
Additional material
Additional file 1: Types of drug administration errors related to
drug ATC classification.
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